🚨Stunning!🚨

REVERSAL in the decline of heart failure ☠️ in the US 1999-2021

1999-2005 ⬇️ ☠️
2005-2012 ⬇️ ☠️
2012-2019 ⬆️ ☠️
2019-2021 ⬆️⬆️☠️

Age-adjusted HF related ☠️ rates higher in 2021 vs 1999!

WT😱🆘

jamanetwork.com/journals/jamac…

JAMA Cardiology Marat Fudim, MD MHS

#ACC24 #SimPub by Alberto Foà in JACC Journals

Fascinating observation from #PARAGONHF — pts w LVEF above 60% were at *higher* risk of hypotension & *lower* likelihood of benefit w #ARNI sacubitril/valsartan

Reinforces current guidance for pt selection

jacc.org/doi/10.1016/j.…

Why does treating #TR improve dyspnoea? Find out more on the importance and effects of #TTEER on left 🫀 #hemodynamics and #HeartFailure

onlinelibrary.wiley.com/doi/10.1002/ej…

Karl-Philipp Rommel Philipp Lurz Holger Thiele Anne Schöber Sebastian Rosch Patrick Sullivan Marco Metra Frederik H. Verbrugge

a 🧵1/6

🖼 Summary of #HFpEF diagnostic scores to facilitate your clinical practice.

It takes time though...
An easy webtool to help you is available!
🌐 cardiologytools.com/hfpef-calculat…

📄 background: doi.org/10.1002/ehf2.1…

#ACC24 Henry Han Karl-Philipp Rommel #HeartFailure #CardioTwitter

🧠Rethinking the Tx paradigm in #HFpEF

Stay tuned for results of #PREDICTHFpEF study @ #DGKJahrestagung

#ProteomicProfiling Saturday 8.30, LBTC II
#StepCount Friday, 4.00, P1615
#Sarcopenia Friday, 9.45, P1297

#HeartFailure #FunctionNotFailure

Philipp Lurz Holger Thiele

🔥 #TTEER improves left 🫀 #hemodynamics and #HeartFailure ‼️

Check out elegant #PVLoop analysis by Karl-Patrik Kresoja Philipp Lurz Sebastian Rosch Maximilian von Roeder Sara Bombace Anne Schöber AGIK Young DGK

Today @ YIA Session #DGKJahrestagung , SimPub in #EJHF : t.ly/szriu

LATE BREAKING news! #TriClip G4 just FDA Medical Devices approved! Finally both repair and replacement options for our pts #FixTR RTHahnMD Paul Nadira Hamid Univ.-Prof. Dr. Ralph Stephan von Bardeleben Philipp Lurz Abbott Cardiovascular DoctorKini Sahil Khera Lucy Parasuram Krishnamoorthy MD

abbott.mediaroom.com/2024-04-02-Abb…

Applying the #TRILUMINATE eligibility criteria to real-world patients

#PCRtricuspid Jonathan Curio and Karl-Philipp Rommel review ✍️ a study 📊based on trial inclusion and exclusion criteria that aimed to compare outcomes in a contemporary “real-world” T-TEER cohort stratified by…

Forgotten no more! New clinical #pvloop study: 'Right Ventricular Performance during acute Hypoxic Exercise.'

Link: physoc.onlinelibrary.wiley.com/doi/10.1113/JP…

Congrats to all involved on this novel study!

#hypoxia #peoplesventricle #heartfailure #cardiology #hemodynamics #pvloop s Journal of Physiology

🌟New on Connect! Should ORBITA2 Change How I Think About CTO PCI? 🤔

📺 Watch now: ow.ly/RYgE50QUYEW

💡 #CRFConnect #CTOPCI #CardioTwitter #CardioX Dan Burkhoff MD PhD David J. Cohen, MD, MSc George Dangas, MD, MACC, MSCAI Juan F. Granada Marty Leon Dr Roxana Mehran Sahil A. Parikh, MD Tricia Rawh TCT Conference

🚀 #StrongHF presentation by Kamile Cerlinskaite-Bajore🇱🇹🇺🇦🌻 at #THT2024

⬆️ QoL across all categ. w/ high-intensity GDMT in #heartfailure ➕ consistent Tx effect across spectrum of baseline QoL

Cardiovascular Research Foundation Alexandre Mebazaa Guillaume Bonnet Dan Burkhoff MD PhD #BethDavison

Sim Pub Circ: Heart Failure: shorturl.at/kwTVX

Apical hypertrophic cardiomyopathy (AHCM) is a rare phenotypic variant of #HCM .

In this CV Case Journal report, we introduce the “blueberry-on-top” phenomenon, a characteristic myocardial strain finding on TTE, to help identify AHCM cases. bit.ly/49DNa1Y

You think #heartfailure is heterogenous? - Then talk to Guillaume Bonnet about #HRPCI - great work disentangling 3 phenotypes using unsupervised #clustering in Abiomed PROTECT III at #THT2024

Novel therapies currently being evaluated in HFpEF at #THT2024

- Pacing
- Splanchnic nerve ablation Marat Fudim, MD MHS
- Percutaneous pericardiotomy
- Renal denervation
- CCM Javed Butler

“2020s is the decade of HFpEF” -Sanjiv J. Shah, MD